CIDRAP newsletters options
The effects of continued distance learning will likely be worse among students already at risk, the authors say.
Deaths have topped 40,000 in US nursing homes or long-term care facilities, a new analysis suggests.
First-year medical residents in Shanghai—500 miles away from the Chinese COVID-19 epicenter of Wuhan—had a steep decline in mood, increased depression and anxiety, and twice the level of fear of workplace violence in the first month of the pandemic, according to a research letter published yesterday in JAMA Network Open.
Drug maker Shionogi & Co. of Osaka, Japan, announced yesterday that the US Food and Drug Administration (FDA) has accepted the company's supplemental New Drug Application (sNDA) and granted Priority Review designation for the use of cefiderocol to treat adults with nosocomial pneumonia.
The cases are in Equateur province, the same area hit by an Ebola outbreak in 2018.
The WHO issues new COVID-19-related guidance on noncommunicable disease and mass gatherings.
Among all patients studied across 24 nations, 51.2% had pulmonary complications and 38.0% died.
Also, a new poll reveals further political divisions about reopening the economy.
A multicenter study published yesterday in Travel Medicine and Infectious Disease shows that 60% of asymptomatic (symptom-free) COVID-19 patients in Sichuan province, China, were diagnosed as having pneumonia on their first computed tomography (CT) scan.
The World Health Organization (WHO) said today that a record number of countries are now monitoring and reporting data on antibiotic resistance but warned that the data reveal worrisome trends.
Also, the US Supreme Court turns down a California church's request to ease the state's restrictions.
Also, the CDC published data pointing to community spread no earlier than late January.
Death rates were 13% and 28% in the 2 studies, with 1 study showing cancer treatment not tied to higher risk.
Trump's announcement draws strong condemnation from public health experts.
"We are deeply aware that no one can fight COVID-19/SARS-CoV-2 on their own. The industry is all in."
Data collected from Canadian acute care hospitals show significant increases in methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci (VRE) bloodstream infections (BSIs) in recent years, according to a study in the Canada Communicable Disease Report (CCDR).
The first major study of diabetics hospitalized with COVID-19 shows more than 1 in 10 die within 7 days of admission, and about 1 in 5 is intubated within 1 week. The study appears today in Diabetologia.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
Ventilation, filtration, disinfection, and avoidance of air recirculation are possible steps.
Brazil's surge shows no sign of slowing, with more than 20,000 new cases.
